MissionIR Articles

  • NovaBay Pharmaceuticals (NBY) Presents at Rodman & Renshaw Conference

    NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. NovaBay has two distinct product categories:…

  • Northwest Biotherapeutics (NWBO) Presents at Rodman & Renshaw Conference

    Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) is developing cancer vaccines designed to treat a broad range of solid tumor cancers more efficiently and cost-effectively than current treatments, and without the side effects of chemotherapy drugs. The…

  • Nivalis Therapeutics (NVLS) Presents at Rodman & Renshaw Conference

    Boulder, Colorado-based Nivalis Therapeutics, Inc. (NASDAQ: NVLS) is discovering solutions for cystic fibrosis. The company is developing a class of disease-modifying therapies designed to preserve intracellular GSNO (S-nitrosoglutathione), an endogenous molecule with cell-signaling effects that…

  • NeuroMetrix (NURO) Presents at Rodman & Renshaw Conference

    NeuroMetrix, Inc. (NASDAQ: NURO) is an innovative health-care company developing wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases and sleep disorders. Established in 1996 by Shai…

  • NephroGenex (NRX) Presents at Rodman & Renshaw Conference

    NephroGenex, Inc. (NASDAQ: NRX) is an innovator in the development of drugs to treat kidney disease with a first indication in diabetic nephropathy. It has been pioneering the development of PYRIDORIN (pyridoxaminedihydrochloride), a late stage…

  • NanoViricides (NNVC) Presents at Rodman & Renshaw Conference

    NanoViricides, Inc. (NYSE: NNVC) is a development stage company with a unique nanomedicine technology. The company is developing nanotechnology-based biomimetic anti-viral medicines called “nanoviricides.” So far, virus-specific nanoviricide drug candidates against five commercially important viral…

  • Nano Dimension (NNDMY) Presents at Rodman & Renshaw Conference

    Nano Dimension (OTC: NNDMY) was founded in 2012 and focuses on the research and development of advanced 3D electronics printing, including a printer for printing PCBs (printed circuit boards), and the development of nanotechnology- based…

  • Cleveland BioLabs (CBLI) Presents at Rodman & Renshaw Conference

    Cleveland BioLabs, Inc. (NASDAQ: CBLI), an innovative biopharmaceutical company, is developing novel approaches to activate the immune system and address serious medical needs. Its proprietary platform of toll-like immune receptor activators has applications in radiation…

  • MicroVision (MVIS) Presents at Rodman & Renshaw Conference

    MicroVision, Inc. (NASDAQ: MVIS) is a world leader in the innovation of a new generation of display technology. The company opens up a world of possibilities by bringing enhanced visibility to the world of mobility.…

  • Merus Labs International (MSLI) Presents at Rodman & Renshaw Conference

    Merus Labs International, Inc. (NASDAQ: MSLI) is on a quest to become a leading specialty pharmaceutical company with a diverse line of products in key global markets, with special geographic focus on North America and…

  • Medovex (MDVX) Presents at Rodman & Renshaw Conference

    Medovex Corporation (NASDAQ: MDVX) is a company dedicated to its mission of “better living through better medicine.” The highly successful and experienced healthcare executives at Medovex have a proven track record of building successful medical…

  • MDxHealth SA (MXDH) Presents at Rodman & Renshaw Conference

    MDxHealth SA (OTCBB: MXDH) is a multinational healthcare company that provides actionable epigenetic information to personalize the diagnosis and treatment of cancer.  The increased adoption of the company’s ConfirmMDx for Prostate Cancer testing solution within…

  • McEwen Mining (MUX) Presents at Rodman & Renshaw Conference

    McEwen Mining, Inc. (NYSE: MUX) is a growing gold and silver producer in the Americas. The company’s goal is to qualify for inclusion in the S&P 500. McEwen Mining’s principal assets include the following: interest…

  • MatinasBioPharma Holdings (MTNB) Presents at Rodman & Renshaw Conference

    MatinasBioPharma Holdings, Inc. (OTCQB: MTNB) is a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective antifungal and anti-bacterial therapeutics for the treatment of serious and life-threatening infections. The company’s lead anti-infective product…

  • MagneGas (MNGA) Presents at Rodman & Renshaw Conference

    Tampa-based MagneGas Corporation (NASDAQ: MNGA) is a technology company that counts a patented process that converts liquid waste into hydrogen based fuels among its inventions. The company sells MagneGas into the metal working market as…

  • Liquidmetal Technologies (LQMT) Presents at Rodman & Renshaw Conference

    Liquidmetal Technologies, Inc. (OTCBB: LQMT) is a leading force in the research, development and commercialization of amorphous metals. The company’s revolutionary class of patented alloys and processes form the basis of high performance materials in…

  • LabStyle Innovations (DRIO) Presents at Rodman & Renshaw Conference

    LabStyle Innovations Corp. (OTC: DRIO) develops and commercializes patented technology providing consumers with laboratory-testing capabilities using smart mobile devices. LabStyle’s flagship product is the Dario™ Diabetes Management Solution. Dario™ empowers people with diabetes to take…

  • La Jolla Pharmaceutical Company (LJPC) Presents at Rodman & Renshaw Conference

    La Jolla Pharmaceutical Company (NASDAQ: LJPC) is focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. The company has several product candidates in…

  • Kamada (KMDA) Presents at Rodman & Renshaw Conference

    KamadaLtd. (NASDAQ: KMDA) is focused on plasma-derived protein therapeutics for orphan indications, and has a commercial product portfolio and a robust late-stage product pipeline. The company uses its proprietary platform technology and know-how for the…

  • Just Energy Group (JE) Presents at Rodman & Renshaw Conference

    Just Energy Group, Inc. (NYSE: JE) is an energy management solutions provider specializing in electricity, natural gas, solar and green energy. With offices located across the United States, Canada, and the United Kingdom, Just Energy…